Pediatric anesthesia and medication safety in dental care for kids and teens
Official title: Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
Funded at University of Pittsburgh at Pittsburgh · NIH-11528266 · Data updated 2026-11-12
A study to reduce the risk of adverse events from high-risk medications used in dental care for children and adolescents.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | May 1, 2026 |
| Project end | April 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $125,813 |
| NIH project number | 3R01DE030657-04S1 |
| Project ID | NIH-11528266 on NIH RePORTER |
Who could benefit from this research
✓Could help
Children and adolescents who may undergo dental procedures involving sedation or medications at risk for adverse events.
✕Less likely to help
Patients not receiving sedation or high-risk medications during dental care may not directly benefit from this study.
What this research studies
This project focuses on improving how dentists manage medicines and sedation in kids to prevent serious complications. It will identify where safety gaps exist in dental practices and develop practical steps that dentists can use to keep children safer. The approach combines review of current prescribing habits with targeted safety practices during conscious sedation and general anesthesia. Results aim to give pediatric patients and their families greater confidence in dental care.
Why it matters
Potential benefit: If successful, the project could lower the chance of dangerous drug events during pediatric dental procedures and improve overall patient safety.
How similar studies have gone: Previous work has shown that targeted safety protocols can reduce adverse events in medical settings, but pediatric dental-specific data are limited.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Suda, Kj — University of Pittsburgh at Pittsburgh
- Study coordinator: Suda, Kj
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.